Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Moderna to Present at Credit Suisse 28th Annual Healthcare Conference


Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Lorence Kim, M.D., Chief Financial Officer, will participate in the Credit Suisse 28th Annual Healthcare Conference in Scottsdale, Arizona on November 13th at 9:45 a.m. ET.

A live webcast of each presentation will be available under "Events & Presentations" in the Investors section of the Moderna website at https://investors.modernatx.com. A replay of each webcast will be archived on Moderna's website for 30 days following the presentations.

About Moderna

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body's cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Moderna's platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.

Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca, Plc. and Merck, Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense and the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Moderna has been named a top biopharmaceutical employer by Science for the past five years. To learn more, visit www.modernatx.com.


These press releases may also interest you

at 13:49
The U.S. Department of State, the Bezos Earth Fund, and The Rockefeller Foundation today announced next steps for the future governance and structure of the Energy Transition Accelerator (ETA), a high-integrity carbon finance platform aimed at...

at 13:46
SBI, the go-to-market (GTM) growth advisory, is pleased to announce the latest expansion to its research on commercial productivity with a report titled: Revive Commercial Productivity by Easing Buying Friction....

at 13:41
Audi Napa Valley is the newest addition to the Fairfield Auto Mall. It will open on May 1st, 2024 in temporary quarters at Volkswagen of Fairfield until its new, permanent facility opens next spring at 2775 Auto Mall Parkway. This is Fairfield...

at 13:25
Synaptics® Incorporated today announced that its Astra SL-Series of embedded AI-native Internet of Things (IoT) processors won the prestigious Best in Show Award from Embedded Computing Design in the category of Microcontrollers, Microprocessors &...

at 13:10
Bilateral Chamber, a leading organization at the forefront of global commerce, hosted His Excellency Mohammed Shyaa Sabbar Al-Sudani, Prime Minister of the Republic of Iraq and his delegation yesterday in Houston, Texas. The Iraqi Prime Minister was...

at 13:05
Versa Networks, the global leader in AI/ML-powered Unified Secure Access Service Edge (SASE) and Software Defined WAN (SD-WAN), today announced it is recognized in the Gartner Magic Quadrant for Security Service Edge (SSE) which will help buyers...



News published on and distributed by: